Consolidated Statements of Cash Flows - USD ($)
|
12 Months Ended |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Cash flows from operating activities: |
|
|
|
| Net income (loss) |
$ 65,855,000
|
$ 303,991,000
|
$ 207,064,000
|
| Adjustments to reconcile net income (loss) to net cash provided by / (used in) operating activities: |
|
|
|
| Bargain purchase gain, net of tax |
0
|
(3,855,000)
|
0
|
| Depreciation and amortization |
27,725,000
|
19,004,000
|
22,677,000
|
| Amortization of debt issuance costs |
2,473,000
|
2,563,000
|
1,512,000
|
| Amortization of debt discount (premium) |
309,000
|
6,727,000
|
4,490,000
|
| Noncash lease expense |
1,429,000
|
734,000
|
(561,000)
|
| Asset Impairment Charges |
0
|
0
|
2,425,000
|
| (Gain) / loss on extinguishment of debt |
0
|
3,890,000
|
(2,719,000)
|
| Share-based awards |
60,272,000
|
65,718,000
|
48,222,000
|
| Change in deferred taxes |
(29,045,000)
|
(14,095,000)
|
70,136,000
|
| Net loss (gain) on disposal of fixed assets |
216,000
|
0
|
0
|
| Contingent liability adjustment |
0
|
(614,000)
|
0
|
| Purchases of securities owned, at fair value |
(1,202,243,000)
|
(1,136,928,000)
|
(1,682,598,000)
|
| Proceeds from sales of securities owned, at fair value |
999,934,000
|
1,007,261,000
|
1,793,934,000
|
| Proceeds from sales of securities sold, not yet purchased, at fair value |
6,621,546,000
|
257,142,000
|
821,829,000
|
| Payments to cover securities sold, not yet purchased, at fair value |
(6,240,064,000)
|
(262,362,000)
|
(850,608,000)
|
| Proceeds from sales of other investments |
28,894,000
|
27,477,000
|
22,453,000
|
| Investment income (loss) principal transactions, net |
(157,798,000)
|
(66,219,000)
|
(161,699,000)
|
| Consolidated Funds |
|
|
|
| Purchases of securities owned, at fair value |
0
|
(4,000,000)
|
(1,912,137,000)
|
| Proceeds from sales of securities owned, at fair value |
0
|
13,748,000
|
1,793,528,000
|
| Payments to Acquire Other Investments Operating Activities, Consolidated Funds |
0
|
0
|
(2,090,000)
|
| Proceeds from other investments |
0
|
14,130,000
|
6,734,000
|
| Investment income (loss) principal transactions, net |
49,235,000
|
5,990,000
|
21,597,000
|
| (Increase) decrease in operating assets: |
|
|
|
| Securities owned, at fair value, held at broker-dealer |
450,760,000
|
(496,443,000)
|
(335,510,000)
|
| Receivable on derivative contracts, at fair value |
(208,556,000)
|
(234,653,000)
|
11,394,000
|
| Securities borrowed |
406,547,000
|
203,584,000
|
(1,153,746,000)
|
| Deposits with clearing organizations, brokers and banks |
23,925,000
|
(6,905,000)
|
(13,197,000)
|
| Receivable from brokers, dealers and clearing organizations |
(250,478,000)
|
115,397,000
|
(1,048,049,000)
|
| Receivable from customers, net of allowance |
117,747,000
|
(55,455,000)
|
1,684,000
|
| Fees receivable, net of allowance |
32,592,000
|
16,919,000
|
(33,991,000)
|
| Insurance and reinsurance assets |
7,717,000
|
(9,465,000)
|
(18,498,000)
|
| Due from related parties |
9,156,000
|
(10,088,000)
|
5,498,000
|
| Other assets |
(30,125,000)
|
(7,273,000)
|
82,124,000
|
| Consolidated Funds |
|
|
|
| Receivable on derivative contracts, at fair value |
0
|
(2,917,000)
|
(19,710,000)
|
| Increase (Decrease) in Receivable from Broker-Dealers and Clearing Organizations, Consolidated Funds |
0
|
0
|
(961,000)
|
| Other assets |
0
|
13,000
|
564,000
|
| Increase (decrease) in operating liabilities: |
|
|
|
| Securities sold, not yet purchased, at fair value, held at broker dealer |
(503,565,000)
|
473,516,000
|
286,105,000
|
| Securities sold under agreement to repurchase |
69,661,000
|
58,433,000
|
(18,208,000)
|
| Payable for derivative contracts, at fair value |
9,502,000
|
(15,997,000)
|
15,399,000
|
| Securities loaned |
(386,734,000)
|
(889,842,000)
|
874,548,000
|
| Payable to brokers, dealers and clearing organizations |
197,356,000
|
171,410,000
|
144,125,000
|
| Payable to customers |
230,802,000
|
752,286,000
|
1,250,102,000
|
| Commission management payable |
12,863,000
|
(13,997,000)
|
45,367,000
|
| Insurance and reinsurance liabilities |
(51,147,000)
|
4,041,000
|
63,856,000
|
| Compensation payable |
(81,185,000)
|
29,833,000
|
134,522,000
|
| Fees payable |
9,579,000
|
(27,350,000)
|
22,293,000
|
| Due to related parties |
(43,000)
|
(51,000)
|
254,000
|
| Accounts payable, accrued expenses and other liabilities |
(1,714,000)
|
11,666,000
|
(7,977,000)
|
| Consolidated Funds |
|
|
|
| Contributions received in advance |
0
|
0
|
450,000
|
| Payable to brokers |
0
|
0
|
8,560,000
|
| Payable for derivative contracts, at fair value |
0
|
0
|
11,967,000
|
| Due To Related Parties, Consolidated Funds |
(23,000)
|
16,000
|
(386,000)
|
| Accounts payable, accrued expenses and other liabilities |
(63,000)
|
(353,000)
|
436,000
|
| Net Cash Provided by (Used in) Operating Activities |
171,594,000
|
306,818,000
|
513,013,000
|
| Cash flows from investing activities: |
|
|
|
| Securities purchased under agreements to resell |
(121,718,000)
|
191,000
|
(191,000)
|
| Purchases of other investments |
(63,875,000)
|
(98,375,000)
|
(48,634,000)
|
| Purchase of business and/or asset acquisition |
187,613,000
|
(63,246,000)
|
(5,647,000)
|
| Cash at deconsolidated entity |
0
|
(5,620,000)
|
(22,382,000)
|
| Proceeds from sales of other investments |
64,017,000
|
99,142,000
|
44,371,000
|
| Purchase of fixed assets and intangibles |
(12,537,000)
|
(11,819,000)
|
(10,721,000)
|
| Proceeds from Sale of Property, Plant, and Equipment |
0
|
4,183,000
|
0
|
| Net Cash Provided by (Used in) Investing Activities |
175,218,000
|
(75,735,000)
|
(43,013,000)
|
| Cash flows from financing activities: |
|
|
|
| Repayments on convertible debt |
0
|
(88,119,000)
|
(69,842,000)
|
| Deferred debt issuance cost |
(72,000)
|
(9,312,000)
|
(1,700,000)
|
| Borrowings on notes and other debt |
4,175,000
|
450,286,000
|
159,821,000
|
| Repayments on notes and other debt |
(10,095,000)
|
(206,433,000)
|
(121,472,000)
|
| Purchase of treasury stock |
(31,078,000)
|
(159,822,000)
|
(47,314,000)
|
| Cash dividends paid |
(15,152,000)
|
(11,373,000)
|
(5,710,000)
|
| Preferred stock dividends paid |
(6,792,000)
|
(6,792,000)
|
(6,792,000)
|
| Contingent liability payment |
(10,076,000)
|
(10,698,000)
|
(5,653,000)
|
| Capital contributions by non-controlling interests in operating entities |
24,311,000
|
36,539,000
|
9,730,000
|
| Capital distributions to non-controlling interests in operating entities |
(10,626,000)
|
(7,601,000)
|
(5,605,000)
|
| Consolidated Funds |
|
|
|
| Capital contributions by non-controlling interests in Consolidated Funds |
0
|
19,017,000
|
375,716,000
|
| Capital distributions to non-controlling interests in Consolidated Funds |
0
|
(21,411,000)
|
(255,597,000)
|
| Net cash provided by / (used in) financing activities |
(55,405,000)
|
(15,719,000)
|
25,582,000
|
| Change in cash and cash equivalents |
291,407,000
|
215,364,000
|
495,582,000
|
| Total cash beginning of period |
1,156,834,000
|
941,470,000
|
445,888,000
|
| Cash and cash equivalents |
1,139,652,000
|
914,343,000
|
645,169,000
|
| Cash collateral pledged |
122,687,000
|
47,494,000
|
110,743,000
|
| Segregated Cash |
185,872,000
|
194,701,000
|
185,141,000
|
| Cash and cash equivalents, Consolidated Funds |
30,000
|
296,000
|
417,000
|
| Total cash at end of period |
1,448,241,000
|
1,156,834,000
|
941,470,000
|
| Supplemental information |
|
|
|
| Cash paid during the year for interest |
187,628,000
|
214,909,000
|
153,653,000
|
| Cash paid during the year for taxes |
50,988,000
|
119,050,000
|
4,783,000
|
| Purchase of treasury stock, at cost, through net settlement |
36,082,000
|
40,392,000
|
15,147,000
|
| Preferred stock dividends declared |
6,792,000
|
6,792,000
|
6,792,000
|
| Cash dividends declared |
16,253,000
|
12,738,000
|
6,851
|
| Net assets (liabilities) acquired upon acquisition (net of cash) |
(187,613,000)
|
23,128,000
|
9,865,000
|
| Increase in noncontrolling interest due to consolidation of entity |
0
|
0
|
48,596,000
|
| Net decrease in non-controlling interests in Consolidated Fund due to deconsolidation of Consolidated Fund |
0
|
74,813,000
|
450,600,000
|
| Common stock issuance for purchase of investment |
0
|
2,500,000
|
0
|
| Common stock issuance upon close of acquisition |
$ 1,881,000
|
$ 23,060,000
|
$ 926,000
|